Hyper-CVAD Treatment of Adult T-cell Acute Lymphoblastic Leukemia in Sweden.
Condition(s):T-cell Acute Lymphoblastic LeukemiaLast Updated:September 25, 2013Completed
Hide Studies Not Open or Pending
Condition(s):T-cell Acute Lymphoblastic LeukemiaLast Updated:September 25, 2013Completed
Condition(s):Precursor Cell Lymphoblastic Leukemia-LymphomaLast Updated:December 21, 2023Completed
Condition(s):T-cell Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia, in Relapse; Refractory Acute Lymphoblastic LeukemiaLast Updated:March 18, 2024Not yet recruiting
Condition(s):T-Cell Acute Lymphoblastic LeukemiaLast Updated:February 8, 2023Recruiting
Condition(s):T-cell Acute Lymphoblastic Leukemia/LymphomaLast Updated:June 29, 2021Completed
Condition(s):Recurrent T Acute Lymphoblastic Leukemia; Refractory T Acute Lymphoblastic LeukemiaLast Updated:February 9, 2024Recruiting
Condition(s):T-Cell Acute Lymphoblastic Leukemia/LymphomaLast Updated:August 4, 2022Recruiting
Condition(s):T-cell Acute Lymphoblastic Leukemia; T-Cell Acute Lymphoblastic LymphomaLast Updated:July 3, 2023Recruiting
Condition(s):T Acute Lymphoblastic Leukemia; T Lymphoblastic LymphomaLast Updated:March 6, 2024Not yet recruiting
Condition(s):T-Acute Lymphoblastic Leukemia; Adult T Lymphoblastic LymphomaLast Updated:October 31, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.